132 related articles for article (PubMed ID: 1911078)
21. The oestrogen-progesterone receptor ratio: an indicator of breast cancer evolution.
Cherubini M; Baxa P; Guarino G
Chir Ital; 2002; 54(4):423-8. PubMed ID: 12239750
[TBL] [Abstract][Full Text] [Related]
22. Progesterone receptor status of breast cancer metastases.
Branković-Magić M; Janković R; Nesković-Konstantinović Z; Nikolić-Vukosavljević D
J Cancer Res Clin Oncol; 2002 Jan; 128(1):55-60. PubMed ID: 11862473
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of intra-tumoral estradiol level in breast cancer patients.
Miyoshi Y; Akazawa K; Kamigaki S; Ueda S; Yanagisawa T; Inoue T; Yamamura J; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2004 Dec; 216(1):115-21. PubMed ID: 15500955
[TBL] [Abstract][Full Text] [Related]
24. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
Cancer; 2006 Jun; 106(12):2576-82. PubMed ID: 16703595
[TBL] [Abstract][Full Text] [Related]
25. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
[TBL] [Abstract][Full Text] [Related]
26. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors].
Ellinidi VN; Anikseeva NV; Goncharova OA; Krasnozhon DA; Fedorov KA
Vopr Onkol; 2004; 50(2):234-6. PubMed ID: 15176229
[TBL] [Abstract][Full Text] [Related]
27. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
[TBL] [Abstract][Full Text] [Related]
28. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
29. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
[TBL] [Abstract][Full Text] [Related]
30. Impact of metastatic estrogen receptor and progesterone receptor status on survival.
Lower EE; Glass EL; Bradley DA; Blau R; Heffelfinger S
Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528
[TBL] [Abstract][Full Text] [Related]
31. [Estradiol and progesterone receptors in loco-regional breast cancer. Clinical and prognostic correlations].
Bolla M; Chedin M; Chambaz E; Gabelle P
Sem Hop; 1984 Jan; 60(2):91-6. PubMed ID: 6322331
[TBL] [Abstract][Full Text] [Related]
32. Negative margin status improves local control in conservatively managed breast cancer patients.
Obedian E; Haffty BG
Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
[TBL] [Abstract][Full Text] [Related]
33. [The criteria of the hormonal sensitivity of breast cancer].
Dryzhak VI
Vopr Onkol; 1992; 38(2):166-73. PubMed ID: 1300701
[TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis.
Berger U; McClelland RA; Wilson P; Greene GL; Haussler MR; Pike JW; Colston K; Easton D; Coombes RC
Cancer Res; 1991 Jan; 51(1):239-44. PubMed ID: 1846309
[TBL] [Abstract][Full Text] [Related]
35. [Comparative study of single-point method and multipoint method in the measurement of estrogen receptor and progesterone receptor in breast cancer].
Shen XQ
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):112-5. PubMed ID: 1618078
[TBL] [Abstract][Full Text] [Related]
36. [Androgen receptors in primary breast carcinoma. Relation to prognostic factors in comparison with estrogen and progesterone receptors].
Reiner G; Jakesz R; Kolb R; Kühnl-Brady K; Reiner A; Schemper M; Spona J
Dtsch Med Wochenschr; 1988 Jun; 113(22):892-7. PubMed ID: 3371221
[TBL] [Abstract][Full Text] [Related]
37. Glutathione S-transferase activity in human breast tumors.
Colovai AI; Stoica A; Cinca SA; Marin M; Gruia M; Condrea I; Petrescu D; Dutu R
Neoplasma; 1992; 39(4):249-54. PubMed ID: 1436238
[TBL] [Abstract][Full Text] [Related]
38. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945
[TBL] [Abstract][Full Text] [Related]
39. [Cytomorphological grading and hormone receptor status in breast carcinoma. Visual studies of smear preparations].
Schenck U; Burger G; Jütting U; Eiermann W
Dtsch Med Wochenschr; 1986 Dec; 111(51-52):1949-53. PubMed ID: 3792219
[TBL] [Abstract][Full Text] [Related]
40. Influence of hormonal status on thermography findings in breast cancer.
Zore Z; Boras I; Stanec M; Oresić T; Zore IF
Acta Clin Croat; 2013 Mar; 52(1):35-42. PubMed ID: 23837271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
